PFE · News · 20261106N

Capital Expenditure Program

PFIZER INC · 2026-11-06 · Importance 46 · Surprise 42

Pfizer plans to invest $650 million over five years to build a 220,000-square-foot manufacturing technology center at its Groton, Connecticut R&D campus. The facility is intended to produce clinical active pharmaceutical ingredients and drug products for Pfizer’s global clinical trials, with operations expected to begin in mid-2031. Pfizer describes the project as a long-term expansion of its R&D and supply-chain capabilities tied to future portfolio needs.